Angiogenic Effects of Recombinant Thymosin Beta 4 in a Mouse Hindlimb Ischemia Model

December 2014 in “ Journal of Biomedical Research ”

Jun-Hwan Moon, Jungwon Lee, Jong-Koo Kang

Studysummary In a mouse model of peripheral vascular disease, this study found that recombinant thymosin β4 treatment increased expression levels of certain proteins, promoting angiogenesis. Our plain-language summary of this paper — not a Tressless recommendation.

The study examined the effects of recombinant thymosin β4 (rTβ4) on angiogenesis in a mouse model of hindlimb ischemia, involving 16 mice treated with rTβ4 and 6 with saline. Results indicated that rTβ4 increased the expression of angiogenic markers HIF-1α, VEGF-1, and eNOS, and reduced muscle fibrosis, as evidenced by histopathological analysis. Immunohistochemistry showed higher CD31 expression, indicating enhanced microvascular formation. Overall, rTβ4 was found to promote angiogenesis and reduce muscle fibrosis, suggesting its potential as a therapeutic option for peripheral arterial disease.

View this study on jbtr.or.kr →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Thymosin Beta 4 Promotes Angiogenesis, Wound Healing, and Hair Follicle Development

118 citations , December 2003 in “Mechanisms of Ageing and Development”

Thymosin β4 helps heal wounds, grow hair, and improve blood vessel formation.

research Thymosin Beta 4 Increases Hair Growth by Activation of Hair Follicle Stem Cells

98 citations , December 2003 in “The FASEB Journal”

In this study, thymosin beta4 was found to stimulate hair growth in normal rats and mice by affecting key processes in the hair follicle cycle, such as stem cell migration and extracellular matrix remodeling.